Overuse of short-acting β(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme

BACKGROUND: Overuse of short-acting β(2)-agonists (SABA) may indicate poor asthma control and adverse health outcomes. Contemporary population-based data on use, risk factors and impact of SABA (over)use on asthma exacerbations and mortality are scarce, prompting initiation of the global SABINA (SAB...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwaru, Bright I., Ekström, Magnus, Hasvold, Pål, Wiklund, Fredrik, Telg, Gunilla, Janson, Christer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160635/
https://www.ncbi.nlm.nih.gov/pubmed/31949111
http://dx.doi.org/10.1183/13993003.01872-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160635/
https://www.ncbi.nlm.nih.gov/pubmed/31949111
http://dx.doi.org/10.1183/13993003.01872-2019

Ejemplares similares